Demonstration of manual drug product filtration system. Learn more about PUPSIT without the pain (https://info.cytivalifesciences.com/fandf-avoid-deviatio...

The biopharma world is moving fast, driven by growing demand for biologics and advanced therapies. Companies need smart technology and agile teams to keep ...

High-throughput research demands tools that keep pace without compromising quality. Traditional sample preparation can slow down workflows, especially when...

Recording of a webinar with Andreas Castan, Kenneth Clapp and Neil Ross "Simplify your cell-culture processes with X-cellerex x-platform bioreactors"

In this webinar, you’ll hear practical insights and considerations for optimizing tangential flow filtration (TFF) workflows in biomanufacturing of advance...

Purifying mRNA remains a persistent challenge for researchers developing vaccines and RNA-based therapeutics. Variability in yield, purity, and reproducibi...

Specific risks associated with SUS integrity assessed as part of the contamination control strategy (CCS).

Virus filtration is a robust mechanism to ensure virus safety of biotherapeutic manufacturing processes and must be validated under simulated worst case pr...

This panel discussion was recorded during the Process development virtual summit in June 2025. The discussion is featuring the R&D scientists behind Cytiv...

Ion exchange chromatography (IEX) is one of the most applied unit operations in the downstream processing of complex biomolecules. The performance of such ...

In silico process development, and especially mechanistic modeling, is gradually gaining acceptance in the bioprocessing industry. In this talk, we explore...

All your efforts and focus on discovery and preclinical work are finally coming to a successful culmination, and now you need to quickly move into clinical...

Here we explore a case study on optimizing and scaling up a plasmid DNA process. Our Fast Trak™ process development services team used design of experiment...

The number of monoclonal antibodies (mAbs) with high-concentration formulation is expected to grow annually by 13% between 2024 and 2029. Meeting this dema...

Due to the high cost and complexity of using real viruses in process development, virus clearance is traditionally tested only in phase 1 and 3 clinical tr...

In silico chromatography process development with the GoSilico™ chromatography modeling software can speed up PD work and simultaneously improve process un...

Using modeling during process development can improve efficiency. In this presentation we discuss the benefits and considerations for process development s...

In this presentation you will learn about how ÄKTA™ avant chromatography system can be used to design in buffer formulations to be used in large scale inli...

In this presentation we describe and evaluate various strategies for the monoclonal antibody (mAb) capture step. We look at factors to consider when choosi...

The US FDA considers buffers as crucial raw materials in the production of active pharmaceutical ingredients (APIs) or intermediates from cell culture or f...